Literature DB >> 25173046

Immunological in vivo effects of B7-H1 deficiency.

Alexandr V Bazhin1, Katharina von Ahn2, Caroline Maier2, Sabine Soltek2, Susanne Serba2, Linda Diehl3, Jens Werner4, Svetlana Karakhanova5.   

Abstract

B7-H1 regulatory protein, a member of the B7-H family, plays a crucial role in the modulation of immune response in healthy steady-state conditions as well as in different pathologies. B7-H1 knockout mice represent an important model to elucidate further molecular and cellular mechanisms involved, among others, in autoimmunity development and cancer progression. However, a deep immunologic characterization of this model is not complete yet. This study examined the role of B7-H1 in vivo further by direct comparison of specifically phenotyped spleen immune-cell subpopulations and their activation and naïve/memory state as well as cytokine profile in wild-type and B7-H1 knockout mice. Our results demonstrated that B7-H1 deficiency in vivo modulates several immunological parameters, including the amount and composition of Gr1(+)CD11b(+) myeloid population, the composition and activation state of the DC compartment, the frequency and status of NK and NKT cells, B-cells, naïve/memory state of CD8 T-cells and production of IL-2 and IL-10 cytokines. Moreover, we observed an increase in the PD-1 expression in the immune cells in B7-H1 knockout mice compared to the wild-type animals. Valuing the importance of B7-H1 knockout mice for their use in disease models, these data underline the role of B7-H1 in vivo also in healthy state and should be taken into account in future studies on this immunosuppressive molecule.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  B7-H1; B7-H1 deficiency; B7-H1 knockout mice; Immunomodulation; Immunosuppressive molecules

Mesh:

Substances:

Year:  2014        PMID: 25173046     DOI: 10.1016/j.imlet.2014.08.013

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  3 in total

1.  Elevated Expression of Programmed Death-1 and Programmed Death Ligand-1 Negatively Regulates Immune Response against Cervical Cancer Cells.

Authors:  Zhifang Chen; Nannan Pang; Rong Du; Yuejie Zhu; Lingling Fan; Donghui Cai; Yan Ding; Jianbing Ding
Journal:  Mediators Inflamm       Date:  2016-09-05       Impact factor: 4.711

2.  The PD-1/PD-L1 Pathway Affects the Expansion and Function of Cytotoxic CD8+ T Cells During an Acute Retroviral Infection.

Authors:  Paul David; Dominik A Megger; Tamara Kaiser; Tanja Werner; Jia Liu; Lieping Chen; Barbara Sitek; Ulf Dittmer; Gennadiy Zelinskyy
Journal:  Front Immunol       Date:  2019-02-05       Impact factor: 7.561

3.  Pivotal antitumor role of the immune checkpoint molecule B7-H1 in pancreatic cancer.

Authors:  Alexandr V Bazhin; Katharina von Ahn; Jasmin Fritz; Henriette Bunge; Caroline Maier; Orkhan Isayev; Florian Neff; Jens T Siveke; Svetlana Karakhanova
Journal:  Oncoimmunology       Date:  2022-03-01       Impact factor: 8.110

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.